Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.63 |
| ▸ | CNR2 | P34972 | 1/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.56 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6432059 | 0.95 | CNR1 (0.61) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL6435539 | 0.90 | CNR1 (0.67) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL27426269 | 0.85 | CNR1 (0.61) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL27426326 | 0.85 | CNR1 (0.61) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL6434335 | 0.83 | CNR1 (0.58) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL23903534 | 0.81 | CNR1 (0.65) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL27426421 | 0.80 | CNR1 (0.56) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL25443355 | 0.80 | CNR1 (0.58) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL28656133 | 0.79 | CNR1 (0.55) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL27426357 | 0.79 | CNR1 (0.55) | CNR1CNR2HDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224163-B1 | USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS | HOFFMANN LA ROCHE (CH) | 2005-03-30 | — | — | EP | disclosed |
| CN-1184964-C | Use of carbonylamino derivatives against CNS disorders | HOFFMANN LA ROCHE (CH) | 2005-01-19 | — | — | CN | disclosed |
| US-6548522-B1 | N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide | HOFFMANN-LA ROCHE INC. | 2003-04-15 | — | — | US | disclosed |
| EP-1224163-A1 | USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001027070-A1 | USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-19 | — | — | WO | disclosed |